SCHEMBL9425835

SCHEMBL9425835

Cc1ccc(-c2nc(CN3CCN(Cc4cccc(C)c4)CC3)c(C)[nH]2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.54
DRD4 P21917 2/20 0.54
DRD3 P35462 2/20 0.54
CTSS P25774 3/20 0.49
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HTT P42858 1/20 0.44
POLB P06746 1/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963868 0.89 DRD2 (0.63) DRD2DRD4DRD3CTSSALDH1A1
SCHEMBL9720664 0.87 DRD2 (0.62) DRD2DRD4DRD3CTSS
SCHEMBL8963661 0.83 CYP3A4 (0.49) DRD2DRD4DRD3CTSSMEN1
SCHEMBL8964019 0.82 DRD2 (0.71) DRD2DRD4DRD3CTSSALDH1A1
Hydrochloric Acid SCHEMBL10644520 0.81 DRD2 (0.56) DRD2DRD4DRD3CTSS
SCHEMBL9720668 0.81 DRD2 (0.55) DRD2DRD4DRD3CTSSALDH1A1
SCHEMBL9725056 0.80 DRD4 (0.67) DRD2DRD4DRD3CTSSLMNA
SCHEMBL8963961 0.78 DRD2 (0.58) DRD2DRD4DRD3CTSSCYP3A4
SCHEMBL8964084 0.77 DRD2 (0.52) DRD2DRD4DRD3CTSSALDH1A1
Lifarizine SCHEMBL676318 0.77 DRD2 (0.57) DRD2DRD4DRD3CTSSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed